{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:49:59Z","timestamp":1779317399820,"version":"3.51.4"},"reference-count":26,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.20945\/2359-3997000000134","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T12:42:27Z","timestamp":1557751347000},"source":"Crossref","is-referenced-by-count":3,"title":["The differences in homeostasis model assessment values in type 2 diabetic patients with different lengths of history of diabetes"],"prefix":"10.20945","author":[{"given":"Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"issue":"11","key":"key20190513124224_B1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/dia.2017.0111","article-title":"Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors","volume":"19","author":"Zhang","year":"2017","unstructured":"1. Zhang T, Ji L, Gao Y, Zhang P, Zhu D, Li X, et al. Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors. Diabetes Technol Ther. 2017;19(11):675-84.","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"key20190513124224_B2","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/oby.21943","article-title":"Relationships Among Obesity, Type 2 Diabetes, and Plasma Cytokines in African American Women","volume":"25","author":"Denis","year":"2017","unstructured":"2. Denis GV, Sebastiani P, Andrieu G, Tran AH, Strissel KJ, Lombardi FL, et al. Relationships Among Obesity, Type 2 Diabetes, and Plasma Cytokines in African American Women. Obesity (Silver Spring). 2017;25(11):1916-20.","journal-title":"Obesity"},{"issue":"7","key":"key20190513124224_B3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/oemed-2016-103948","article-title":"Associations between persistent organic pollutants, type 2 diabetes, diabetic nephropathy and mortality","volume":"74","author":"Grice","year":"2017","unstructured":"3. Grice BA, Nelson RG, Williams DE, Knowler WC, Mason C, Hanson RL, et al. Associations between persistent organic pollutants, type 2 diabetes, diabetic nephropathy and mortality. Occup Environ Med. 2017;74(7):521-7.","journal-title":"Occup Environ Med"},{"issue":"9","key":"key20190513124224_B4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.molmet.2017.06.019","article-title":"Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis","volume":"6","author":"Chen","year":"2017","unstructured":"4. Chen C, Cohrs CM, Stertmann J, Bozsak R, Speier S. Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis. Mol Metab. 2017;6(9):943-57.","journal-title":"Mol Metab"},{"issue":"8","key":"key20190513124224_B5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/0091270009349711","article-title":"A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes","volume":"50","author":"Ribbing","year":"2010","unstructured":"5. Ribbing J, Hamr\u00e9n B, Svensson MK, Karlsson MO. A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes. J Clin Pharmacol. 2010;50(8):861-72.","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"key20190513124224_B6","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2017-00828","article-title":"Pancreas Fat and \u03b2 Cell Mass in Humans With and Without Diabetes: An Analysis in the Japanese Population","volume":"102","author":"Murakami","year":"2017","unstructured":"6. Murakami R, Saisho Y, Watanabe Y, Inaishi J, Tsuchiya T, Kou K, et al. Pancreas Fat and \u03b2 Cell Mass in Humans With and Without Diabetes: An Analysis in the Japanese Population. J Clin Endocrinol Metab. 2017;102(9):3251-60.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20190513124224_B7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/me.2014-1293","article-title":"Activation of Melatonin Signaling Promotes \u03b2-Cell Survival and Function","volume":"29","author":"Costes","year":"2015","unstructured":"7. Costes S, Boss M, Thomas AP, Matveyenko AV. Activation of Melatonin Signaling Promotes \u03b2-Cell Survival and Function. Mol Endocrinol. 2015;29(5):682-92.","journal-title":"Mol Endocrinol"},{"issue":"5","key":"key20190513124224_B8","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3001","article-title":"Serum uric acid to creatinine ratio correlates with \u03b2-cell function in type 2 diabetes","volume":"34","author":"Li","year":"2018","unstructured":"8. Li M, Gu L, Yang J, Lou Q. Serum uric acid to creatinine ratio correlates with \u03b2-cell function in type 2 diabetes. Diabetes Metab Res Rev. 2018;34(5):e3001.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"key20190513124224_B9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/EP-2017-0027","article-title":"DPP4 inhibitor sitagliptin as a potential treatment option in metformin- intolerant obese women with polycystic ovary syndrome: a pilot randomized study","volume":"24","author":"Ferjan","year":"2018","unstructured":"9. Ferjan S, Janez A, Jensterle M. DPP4 inhibitor sitagliptin as a potential treatment option in metformin- intolerant obese women with polycystic ovary syndrome: a pilot randomized study. Endocr Pract. 2018;24(1):69-77.","journal-title":"Endocr Pract"},{"issue":"4","key":"key20190513124224_B10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175498","article-title":"Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic \u03b2 cells","volume":"12","author":"Liu","year":"2017","unstructured":"10. Liu S, Du F, Li X, Wang M, Duan R, Zhang J, et al. Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic \u03b2 cells. PLoS One. 2017;12(4):e0175498.","journal-title":"PLoS One"},{"issue":"3","key":"key20190513124224_B11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","article-title":"Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus","volume":"6","author":"Tangvarasittichai","year":"2015","unstructured":"11. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6(3):456-80.","journal-title":"World J Diabetes"},{"issue":"2","key":"key20190513124224_B12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-14-0335","article-title":"Resveratrol and curcumin enhance pancreatic \u03b2-cell function by inhibiting phosphodiesterase activity","volume":"223","author":"Rouse","year":"2014","unstructured":"12. Rouse M, Youn\u00e8s A, Egan JM. Resveratrol and curcumin enhance pancreatic \u03b2-cell function by inhibiting phosphodiesterase activity. J Endocrinol. 2014;223(2):107-17.","journal-title":"J Endocrinol"},{"issue":"5","key":"key20190513124224_B13","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1172\/JCI83657","article-title":"Stress-impaired transcription factor expression and insulin secretion in transplanted human islets","volume":"126","author":"Dai","year":"2016","unstructured":"13. Dai C, Kayton NS, Shostak A, Poffenberger G, Cyphert HA, Aramandla R, et al. Stress-impaired transcription factor expression and insulin secretion in transplanted human islets. J Clin Invest. 2016;126(5):1857-70.","journal-title":"J Clin Invest"},{"issue":"4","key":"key20190513124224_B14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbrc.2015.10.038","article-title":"Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key \u03b2-cell factors under diabetic conditions","volume":"467","author":"Shimo","year":"2015","unstructured":"14. Shimo N, Matsuoka TA, Miyatsuka T, Takebe S, Tochino Y, Takahara M, et al. Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key \u03b2-cell factors under diabetic conditions. Biochem Biophys Res Commun. 2015;467(4):948-54.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"key20190513124224_B15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.dsx.2014.09.018","article-title":"Type 2 diabetes mellitus: Role of melatonin and oxidative stress","volume":"9","author":"Zephy","year":"2015","unstructured":"15. Zephy D, Ahmad J. Type 2 diabetes mellitus: Role of melatonin and oxidative stress. Diabetes Metab Syndr. 2015;9(2):127-31.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"key20190513124224_B16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/dom.12858","article-title":"Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes","volume":"19","author":"Kramer","year":"2017","unstructured":"16. Kramer CK, Zinman B, Choi H, Connelly PW, Retnakaran R. Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes. Diabetes Obes Metab. 2017;19(5):744-8.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"key20190513124224_B17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/JOE-16-0317","article-title":"SIRT6 protects against palmitate-induced pancreatic \u03b2-cell dysfunction and apoptosis","volume":"231","author":"Xiong","year":"2016","unstructured":"17. Xiong X, Sun X, Wang Q, Qian X, Zhang Y, Pan X, et al. SIRT6 protects against palmitate-induced pancreatic \u03b2-cell dysfunction and apoptosis. J Endocrinol. 2016;231(2):159-65.","journal-title":"J Endocrinol"},{"issue":"2","key":"key20190513124224_B18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.hepres.2005.09.010","article-title":"Mechanisms of insulin resistance caused by nutrient toxicity","volume":"33","author":"Proietto","year":"2005","unstructured":"18. Proietto J. Mechanisms of insulin resistance caused by nutrient toxicity. Hepatol Res. 2005;33(2):87-91.","journal-title":"Hepatol Res"},{"issue":"6","key":"key20190513124224_B19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4161\/isl.22720","article-title":"\u03b2-cell metabolic alterations under chronic nutrient overload in rat and human islets","volume":"4","author":"Vernier","year":"2012","unstructured":"19. Vernier S, Chiu A, Schober J, Weber T, Nguyen P, Luer M, et al. \u03b2-cell metabolic alterations under chronic nutrient overload in rat and human islets. Islets. 2012;4(6):379-92.","journal-title":"Islets"},{"issue":"7","key":"key20190513124224_B20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180285","article-title":"Active subfractions of Abelmoschus esculentus substantially prevent free fatty acid-induced \u03b2 cell apoptosis via inhibiting dipeptidyl peptidase-4","volume":"12","author":"Huang","year":"2017","unstructured":"20. Huang CN, Wang CJ, Lee YJ, Peng CH. Active subfractions of Abelmoschus esculentus substantially prevent free fatty acid-induced \u03b2 cell apoptosis via inhibiting dipeptidyl peptidase-4. PLoS One. 2017;12(7):e0180285.","journal-title":"PLoS One"},{"issue":"4","key":"key20190513124224_B21","doi-asserted-by":"crossref","first-page":"E430","DOI":"10.1073\/pnas.1514375113","article-title":"Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic \u03b2-cells and hepatocytes","volume":"113","author":"Mugabo","year":"2016","unstructured":"21. Mugabo Y, Zhao S, Seifried A, Gezzar S, Al-Mass A, Zhang D, et al. Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic \u03b2-cells and hepatocytes. Proc Natl Acad Sci U S A. 2016;113(4):E430-9.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"key20190513124224_B22","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/en.2017-00366","article-title":"A Sustained Activation of Pancreatic NMDARs Is a Novel Factor of \u03b2-Cell Apoptosis and Dysfunction","volume":"158","author":"Huang","year":"2017","unstructured":"22. Huang XT, Yue SJ, Li C, Huang YH, Cheng QM, Li XH, et al. A Sustained Activation of Pancreatic NMDARs Is a Novel Factor of \u03b2-Cell Apoptosis and Dysfunction. Endocrinology. 2017;158(11):3900-13.","journal-title":"Endocrinology"},{"issue":"10","key":"key20190513124224_B23","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.2337\/db16-1352","article-title":"Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced \u03b2-Cell Apoptosisand JNK Pathway Activation","volume":"66","author":"Templin","year":"2017","unstructured":"23. Templin AT, Samarasekera T, Meier DT, Hogan MF, Mellati M, Crow MT, et al. Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced \u03b2-Cell Apoptosisand JNK Pathway Activation. Diabetes. 2017;66(10):2636-45.","journal-title":"Diabetes"},{"issue":"12","key":"key20190513124224_B24","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s00125-015-3738-x","article-title":"Physical activity energy expenditure vs cardio- respiratory fitness level in impaired glucose metabolism","volume":"58","author":"Lidegaard","year":"2015","unstructured":"24. Lidegaard LP, Hansen AL, Johansen NB, Witte DR, Brage S, Lauritzen T, et al. Physical activity energy expenditure vs cardio- respiratory fitness level in impaired glucose metabolism. Diabetologia. 2015;58(12):2709-17.","journal-title":"Diabetologia"},{"issue":"3","key":"key20190513124224_B25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00125-016-4165-3","article-title":"Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study","volume":"60","author":"den Biggelaar","year":"2017","unstructured":"25. den Biggelaar LJ, Sep SJ, Eussen SJ, Mari A, Ferrannini E, van Greevenbroek MM, et al. Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study. Diabetologia. 2017;60(3):432-41.","journal-title":"Diabetologia"},{"issue":"3","key":"key20190513124224_B26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-016-4174-2","article-title":"Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide","volume":"60","author":"Courtade","year":"2017","unstructured":"26. Courtade JA, Wang EY, Yen P, Dai DL, Soukhatcheva G, Orban PC, et al. Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide. Diabetologia. 2017;60(3):453-63.","journal-title":"Diabetologia"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T12:42:37Z","timestamp":1557751357000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972019005003103&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":26,"alternative-id":["10.20945\/2359-3997000000134"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000134","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]}}}